MTL Cannabis Corp., based in Ontario and the parent company of several Canadian cannabis companies, has named Jason Nalewany as its Chief Financial Officer, replacing Peili Miao. MTL Cannabis, previously known as Canada House Cannabis Group, owns the following subsidiaries: Montréal Medical Cannabis Inc., Abba Medix Corp., IsoCanMed Inc., and Canada House Clinics Inc.
CEO Michael Perron stated, “Jason has been a key part of MTL over the past two years, specifically operating as the driving force to help complete the RTO transaction this past summer.”
Before joining MTL Cannabis, Jason Nalewany served as the CFO of Montreal Cannabis Medical Inc. and held senior positions at MediPharm Labs, an LP based in Barrie, Ontario. Nalewany is a Canadian chartered professional accountant and a graduate of the University of Victoria.
On July 28, 2023, Montréal Cannabis Médical Inc. completed a reverse takeover of MTL Cannabis. Shares of MTL Cannabis Corp. are traded under the symbol MTLC on the Canadian Securities Exchange.
Have you read?
The world’s largest economies in 2023.
Ranked: Safest Countries in the World, 2023.
Countries With the Most Female Billionaires, 2023.
Economy Rankings: Largest countries by GDP, 2023.
The Global Passport Index: The World’s Most Powerful Passports.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
SUBSCRIBE NEWSLETTER
